•  
  •  
  •  
  •  

2026-05-28 21:49:22

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores

Keywords Selected:  Inspection

Stock Report

  • US FDA Inspection at Alkem Laboratories Ltd's CRO facility located at Taloja
  • US FDA Inspection at Alkem Laboratories Ltd's manufacturing facility located at Amaliya, Daman
  • Solara announces successful closure of US FDA inspection of its Puducherry Facility with continued state of cGMP compliance
  • USFDA inspection at Rubicon Research Ltd's R&D Facility
  • USFDA inspection at Somerset facility of Lupin Ltd
  • USFDA inspection at Cipla Ltd's manufacturing facility in Goa, India
  • Morepen Secures Fourth Consecutive USFDA Inspection with Zero Observations
  • Granules Life Sciences Receives VAI Classification following US FDA Inspection
  • Unit-IV of APL Healthcare Ltd classified as VAI by the US FDA
  • Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility
  • USFDA inspection at the manufacturing facility of Enzene Biosciences Limited
  • Strides Pharma Inc's Chestnut Ridge facility gets 4 observations from USFDA
  • US FDA determines Sun Pharma's Baska facility inspection classification as OAI
  • Successful completion of USFDA inspection at Vizag facility
  • Apitoria Pharma Pvt Ltd receives 3 observations from USFDA for Unit-V
  • GMP Inspection by Malta Medicines Authority at Alkem's manufacturing facility located at Daman, India
  • Ipca Laboratories Ltd receives 3 observations from USFDA for API facility at Tarapur
  • Granules India's Packaging Facility in US Completes FDA inspection with Zero Observations
  • Glenmark Pharmaceuticals Ltd update on USFDA PAI at Chhatrapati Sambhajinagar Facility
  • Innoxel Lifesciences Successfully Completes EU GMP Inspection by Belgium's FAMHP
  • GMP Inspection by Ministry of Health, Armenia at Alkem's manufacturing facility located at Sikkim, India
  • Shilpa Medicare Ltd receives 8 observations from USFDA for Unit 4 at Jadcherla
  • Lupin Ltd receives 7 observations from USFDA for Goa manufacturing facility
  • NATCO Pharma Ltd receives 7 Observations from USFDA for API unit at Manali, Chennai

Latest Post

  • The Sukhjit Starch and Chemicals Ltd delivers a Revenue Growth of 16.89% QoQ in Q4 FY26 with Optimistic Outlook
  • Power and Instrumentation Gujarat Ltd receives additional work order worth Rs. 7.13 crore
  • Corona Remedies Accelerates India and World Market Expansion with EU-GMP Accreditations for Hormone and Oral Solid Dosage Facility
  • Kissht delivers first results post-listing: FY26 PAT up 75% YoY to ₹281 Cr; AUM crosses ₹7,000 Cr milestone
  • Likhitha Infrastructure Ltd receives order worth Rs. 121.04 crores


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025